Selvita S.A. (FRA:787)

Germany flag Germany · Delayed Price · Currency is EUR
10.95
-0.10 (-0.90%)
At close: Dec 4, 2025
-7.36%
Market Cap 202.61M
Revenue (ttm) 87.62M
Net Income (ttm) -678.22K
Shares Out n/a
EPS (ttm) -0.04
PE Ratio n/a
Forward PE 52.00
Dividend n/a
Ex-Dividend Date n/a
Volume n/a
Average Volume n/a
Open 10.95
Previous Close 11.05
Day's Range 10.95 - 10.95
52-Week Range 6.18 - 12.26
Beta n/a
RSI 63.34
Earnings Date Nov 20, 2025

About Selvita

Selvita S.A. operates as a contract research organization worldwide. The company offers drug discovery services in the areas of AI-driven drug discovery, antibody drug discovery, structural biology, recombinant protein production, assay development and screening, computer-aided drug design, medicinal and synthetic chemistry, scale-up, ADME/DMPK, in vitro and In Vivo pharmacology, translational research, and toxicology. It also develops drugs for therapeutic areas, such as oncology, infectious diseases, immunology, neurology, respiratory, and ot... [Read more]

Industry Commercial Physical and Biological Research
Founded 2007
Employees 969
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol 787
Full Company Profile

Financial Performance

Financial numbers in PLN Financial Statements

News

There is no news available yet.